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RAB18, RAB3GAP1, RAB3GAP2 and TBC1D20 are each mutated in Warburg
Micro syndrome, a rare autosomal recessive multisystem disorder. RAB3GAP1
and RAB3GAP2 form a binary ‘RAB3GAP’ complex that functions as a
guanine-nucleotide exchange factor (GEF) for RAB18, whereas TBC1D20
shows modest RAB18 GTPase-activating (GAP) activity in vitro. Here, we
show that in the absence of functional RAB3GAP or TBC1D20, the level, local-
ization and dynamics of cellular RAB18 is altered. In cell lineswhere TBC1D20
is absent from the endoplasmic reticulum (ER), RAB18 becomes more stably
ER-associated and less cytosolic than in control cells. These data suggest
that RAB18 is a physiological substrate of TBC1D20 and contribute to a
model in which a Rab-GAP can be essential for the activity of a target Rab.
Together with previous reports, this indicates that Warburg Micro syndrome
can be caused directly by loss of RAB18, or indirectly through loss of RAB18
regulators RAB3GAP or TBC1D20.1. Background
WarburgMicro syndrome (MIM 600118, 614225, 615222, 615663) is a rare autoso-
mal recessive disorder characterized by severe eye and brain abnormalities [1,2]. It
can be caused by loss-of-function mutations in RAB18, RAB3GAP1, RAB3GAP2
or TBC1D20 [3–6]. Importantly, a mutation in any one of the known disease
genes produces a clinically indistinguishable condition [6,7]. Affected children
are born with cataracts and other eye abnormalities including microphthalmia,
microcornea and atonic pupils. They develop postnatal-onset microcephaly and
have cerebral malformations that include hypogenesis of the corpus callosum
and polymicrogyria. There is usually significant developmental delay and
affected individuals are normally unable to sit independently, walk or talk.
Rab proteins are small GTPases of the Ras superfamily (reviewed in [8]).
Proteins in this class are often referred to as molecular switches because they
adopt different conformations depending on whether they are bound to GDP or
GTP. It is thought that in a GDP-bound state they are largely inactive, whereas
in a GTP-bound state they are able to mediate downstream effects by interact-
ing with binding proteins referred to as effectors. The switching between these
states is governed by two classes of regulatory protein: the guanine-nucleotide
exchange factors (GEFs), which mediate the exchange of bound GDP for GTP,
and the GTPase-activating proteins (GAPs), which stimulate the GTP hydrolysis
activityof their substrateGTPase(s). Rabproteins alsoundergo cycles ofmembrane
association and dissociation that accompany their cycles of GTP binding and
hydrolysis. This is accomplished via GDP-dissociation inhibitor (GDI) proteins
that mediate the extraction of membrane-associated, GDP-bound Rabs into the
cytosol. The proper retargeting of cytosolic Rab proteins back onto cellular
membranes requires GDI and may also require a GDI-displacement factor (GDF).
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ing a complex with GAP activity towards Rab3 isoforms
before their involvement in Micro syndrome, or that of
RAB18, was known [9,10]. Recent work has now shown that
the complex also functions as a RAB18GEF [11]. Given that
the symptoms of individuals lacking a functional RAB3GAP1
or RAB3GAP2 mimic those of individuals lacking functional
RAB18, this implies that in the absence of cellular RAB18GEF
activity, RAB18 is unable to fulfil its cellular role.
The relationship between TBC1D20 and the other disease
gene products has not been explicitly explored. However,
multiple observations link its function to that of the
other proteins and suggest that, like RAB3GAP, it might
regulate RAB18. First, mice with a loss-of-function muta-
tion in Tbc1d20 show a highly similar ocular phenotype to
Rab18(2/2) mice, exhibiting nuclear cataracts [6,12,13]. Further,
at the cellular level, patient fibroblasts, TBC1D20 or RAB18-
deficient mouse fibroblasts, and Cos7 cells in which the disease
genes have been knocked down all show similarly altered lipid
droplet (LD) formation with respect to controls [6,11,12].
Finally, although characterized as a GAP for Rab1 and Rab2
isoforms, TBC1D20 shows modest in vitro GAP activity
towards RAB18 [14].
In this report, we show that RAB18 can be targeted from
the cytosol to the cis-Golgi in human fibroblasts, where it can
then be stabilized by RAB3GAP/RAB18GEF. Further, we
show that TBC1D20 functions to promote RAB18 dissociation
from the endoplasmic reticulum (ER) membrane into the
cytosol, probably though stimulating RAB18 GTP-hydrolysis.2. Results and discussion
2.1. Loss of the RAB3GAP complex or TBC1D20 leads to
an increase in cellular levels of RAB18
We began quantitative PCR (qPCR) and western blot analysis
of a panel of control and patient-derived human skin
fibroblasts [6,11] to determine the effect of mutations in
RAB3GAP1, TBC1D20 and RAB18 on transcript and protein
levels of all of the known Micro syndrome disease genes
(figure 1). As expected, reduced levels of the cognate tran-
scripts resulted from the splicing mutation in RAB3GAP1,
RAB3GAP1(c.649-2A.G), and the nonsense mutation in
TBC1D20, TBC1D20(p.Gln98*), when compared with con-
trols (figure 1a). This is consistent with these mutations
introducing premature stop codons and thereby rendering
the transcripts susceptible to nonsense-mediated decay
(NMD). Consistent with this, no RAB3GAP1 or TBC1D20
protein was detectable by western blot in respective cell lines,
suggesting that the mutations completely abolish protein
expression (figure 1b). The missense mutation in RAB18,
RAB18(p.Leu24Gln), ablates nucleotide-binding [4] but did
not affect levels of RAB18 transcript.
Two apparent trans-acting post-transcriptional effects were
observed. First, we saw that RAB3GAP2 protein was almost
undetectable in RAB3GAP1(c.649-2A.G) cells (figure 1b).
This was not unexpected as a corresponding effect has been
reported in Rab3gap1(2/2) mice and in Cos7 and HeLa cells
in which RAB3GAP1was knocked down [11,15]. A reasonable
explanation for this is that RAB3GAP1 and RAB3GAP2 func-
tion as a complex and that RAB3GAP1 is required to
maintain RAB3GAP2 stability [15]. Next, we observed thatlevels of RAB18 were elevated in both RAB3GAP1(c.649-
2A.G) and TBC1D20(p.Gln98*) cells (figure 1b and the
electronic supplementary material, figure S1a). The levels of
RAB18 transcript were comparable between each cell line
and controls (figure 1c).
To further explore the effects of loss of TBC1D20 on levels
of RAB18, we compared immortalizedmouse embryonic fibro-
blasts (mEFs) heterozygous and homozygous for the ‘blind-
sterile’ (bs) Tbc1d20 loss-of-function mutation TBC1D20
p.[Phe231Met; p.Arg232 _Val235del] [6]. As in the patient
fibroblasts, an increase in levels of RAB18 was observed
(figure 1b and the electronic supplementary material, figure
S1a). The levels of Rab18 transcript were comparable to those
in controls (figure 1c). Furthermore, when either the human
or mouse TBC1D20-deficient cells were treated with cyclohex-
imide to inhibit protein synthesis, the reduction in RAB18
levels over time was slowed compared with controls. This
suggests that RAB18 is less rapidly degraded in these cells
(electronic supplementary material, figure S1b,c). In treated
RAB3GAP1(c.649-2A.G) cells, reduction in RAB18 levels
occurred at a similar rate to that in controls (electronic supple-
mentary material, figure 1b). This suggests that any alteration
in RAB18 degradation in these cells is more subtle than in the
TBC1D20-deficient lines. Levels of the TBC1D20 substrate
RAB1A were unchanged in TBC1D20(p.Gln98*) cells and bs
mEFs when compared with controls (electronic supplementary
material, figure S1d).2.2. The RAB3GAP complex stabilizes RAB18 at the
cis-Golgi in human fibroblasts
To further examine the relationship between the RAB3GAP
complex and RAB18, we first investigated the localization
of RAB3GAP1 in human control fibroblasts. We then com-
pared this with the localization of RAB18 in control and
RAB3GAP1(c.649-2A.G) cells. Endogenous RAB3GAP1 is
known to localize to punctae overlapping with ER tubules in
the cell periphery, with pronounced enrichment at a peri-
nuclear region of Cos7 and HeLa cells [11]. It has also been
reported to localize to the Golgi in human fibroblasts [16]. To
determine its localization in our patient fibroblasts, we com-
pared the pattern of staining produced by an antibody to
RAB3GAP1 in control cells with that in RAB3GAP1(c.649-
2A.G) cells in which the protein is absent (electronic
supplementary material, figure S2a). Although some back-
ground staining was evident, there was clear specific signal
in the perinuclear region in the control cells. RAB18 has been
reported to localize to the cis-Golgi membrane [17,18]. To test
if the ‘RAB3GAP1-specific’ signal corresponded to the cis-
Golgi, we co-stained cells with antibodies to RAB3GAP1
and GM130 and saw clear colocalization between signals
(figure 2a). This colocalization was not affected in either
RAB18(p.Leu24Gln) or TBC1D20(p.Gln98*) cells (electronic
supplementary material, figure S2b).
No specific signal could be identified using the available
RAB18 antibodies. However, the localization of GFP-RAB18
has been shown to mirror that of its endogenous counterpart
[18]. We therefore proceeded by transiently transfecting
cells to express this fusion protein and imaging only cells
expressing it at a relatively low level. In both control and
RAB3GAP1(c.649-2A.G) cells, RAB18 showed a character-
istic reticular localization pattern with enrichment at the
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Figure 1. Loss-of-function mutations in TBC1D20 or RAB3GAP1 are associated with increased levels of RAB18 protein but not transcript. (a) Quantitative RT-PCR
(qPCR) shows that levels of TBC1D20 and RAB3GAP transcripts are reduced compared to controls in TBC1D20( p.Gln98*) and RAB3GAP1(c.649-2A.G) patient fibro-
blasts, respectively, but that levels of RAB18 transcript in RAB18( p.Leu24Gln) fibroblasts are comparable. (b) Western blotting shows levels of RAB3GAP1, RAB3GAP2,
TBC1D20 and RAB18 protein in control and patient fibroblasts and blind-sterile fibroblasts. Blotting for tubulin serves as a control. Each lane on the blots shown
corresponds to an individual lysate sample, and each blot is representative of at least three independent experiments. (c) qPCR shows that levels of RAB18 transcript
are comparable in control and mutant cell lines. qPCR data shown are derived from analysis of at least three cDNAs per genotype, each analysed in triplicate. Primers
were designed using the Universal ProbeLibrary Assay Design Center (Roche) and are listed in the electronic supplementary material, table S1. Error bars represent
s.e.m. *p, 0.005, unpaired Student’s t-test.
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in which it was shown to localize to the ER membrane
as well as to the cis-Golgi [17,18]. To confirm the cis-Golgi
component of RAB18 fluorescence, we again co-stained
cells for GM130 (figure 2b). There was clear colocaliza-
tion between RAB18 and this marker in both control and
RAB3GAP1(c.649-2A.G) cells.
The RAB3GAP complex functions as a RAB18GEF capable
of ectopically targeting RAB18 to membranes. Knockdown of
the complex in Cos7 and HeLa cells leads to the redistribution
of RAB18 from cell membranes to the cytosol [11]. It was there-
fore surprising that in RAB3GAP1(c.649-2A.G) cells that lackRAB3GAP, there was no change in RAB18 localization. Rab
proteins enter the cytosolic compartment when GDP-bound
and complexed to GDI. Rab-GEFs promote more stable mem-
brane association by reducing the proportion of GDP-bound
Rab. However, Rabs in the cytosolic compartment are initially
retargeted to ‘sample’ cellular membranes in a manner inde-
pendent of Rab-GEFs [19]. We therefore reasoned that in
the RAB3GAP1(c.649-2A.G) cells, efficient retargeting of
RAB18 from the cytosol to the membrane could account for
the lack of a ‘bulk-shift’ into the cytosol. Nevertheless, the
loss of a RAB18GEF should be reflected by a more transient
association of RAB18 with cellular membranes in these cells.
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Figure 2. RAB18 dynamics at the Golgi are altered in RAB3GAP1(c.649-2A.G)
fibroblasts. (a) RAB3GAP1 colocalizes with staining for GM130 in control human
fibroblasts. (b) GFP-RAB18 colocalizes with staining for GM130 in control and RAB3-
GAP1(c.649-2A.G) fibroblasts. (c) GFP-RAB18 dynamics at the ER in control and
RAB3GAP1(c.649-2A.G) fibroblasts. (d ) GFP-RAB18 dynamics at the Golgi in con-
trol and RAB3GAP1(c.649-2A.G) fibroblasts. Indicated ROIs in each cell were
bleached with high-intensity laser. Fluorescence recovery in the ROI was recorded
over time and normalized with respect to overall cell fluorescence. Data were com-
bined from at least 15 cells per condition and are representative of two independent
experiments. Error bars represent s.e.m. Scale bars, 10 mm. #p, 0.05 and *p,
0.01, unpaired Student’s t-test.
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2A.G) cells, we employed fluorescence recovery after
photobleaching (FRAP; figure 2c–d). Cells were transfectedto express GFP-RAB18, and comparable fluorescent regions
of interest (ROIs) within them were subjected to photo-
bleaching with high-intensity laser light. The recovery of
fluorescence in these regions was then recorded over time.
Fluorescence recovery profiles following bleaching of tagged
Rab proteins are complex functions reflecting fluorescence
recovery frommultiple sources [20]. A fast component of fluor-
escence recovery is the result of the simple diffusion of cytosolic
fluorescent protein into the ROI following bleaching. Further
components of recovery result from the lateral diffusion of
membrane-associated fluorescent protein and the movement
of the membranes themselves. In addition, fluorescence recov-
ery is influenced by the rate of exchange of fluorescent protein
between the cytosol and membrane, as discussed above.
Fluorescence recovery profiles from bleaching of GFP-
RAB18 within ‘ER’ ROIs were not significantly different in con-
trol and RAB3GAP1(c.649-2A.G) cells (figure 2c). This
suggests that in these cells at least, RAB3GAP does not affect
RAB18 dynamics at the ER. However, bleaching of perinuclear,
cis-Golgi, regions resulted in significantly and reproducibly
different fluorescence recovery profiles between control and
RAB3GAP1(c.649-2A.G) cells (figure 2d). As in bleaching at
theER, the extentofGFP-RAB18 fluorescence recovery recorded
at the first post-bleaching timepoint (a scan begun approx. 0.5 s
following completion of the bleaching scan) was comparable
between the cell lines, suggesting that a similar fraction of
GFP-RAB18 is cytosolic in these cells. However, fluorescence
recovery in the RAB3GAP1(c.649-2A.G) cells then procee-
ded more rapidly and was more complete than in control
cells. This suggests that in control cells, RAB3GAP serves to
stabilize theassociationbetweenRAB18and the cis-Golgi, a con-
clusion supported by the enrichment of RAB3GAP1 at this
location. In the RAB3GAP1(c.649-2A.G) cells, more rapid
fluorescence recovery reflects a more transient, less stable,
cis-Golgi association in the absence of RAB3GAP.
2.3. RAB18 dynamics at the endoplasmic reticulum are
altered in TBC1D20-deficient human fibroblasts,
mouse fibroblasts and HeLa cells
Having established that RAB3GAP influences RAB18
dynamics, we next investigated the relationship between
TBC1D20 and RAB18. In TBC1D20(p.Gln98*) cells, the reti-
cular ‘ER’ RAB18 staining pattern was present, but the
perinuclear, cis-Golgi, enrichment of RAB18 fluorescence
was completely absent (figure 3a). To confirm that RAB18
enrichment at the cis-Golgi was lost in TBC1D20(p.Gln98*)
cells, we stained them for GM130. As shown in figure 3a, the
clear colocalization of RAB18 and GM130 in controls was not
seen in TBC1D20(p.Gln98*) cells. Together with the increase
in RAB18 levels in the TBC1D20-deficient cells (figure 1b
and electronic supplementary material, figure S1a), this find-
ing strongly suggests a functional link between TBC1D20
and RAB18.
TBC1D20 is an integral ER protein with known GAP
activity towards RAB18 in vitro [14]. Therefore, the loss of
Golgi RAB18 enrichment in TBC1D20(p.Gln98*) cells suggests
that TBC1D20-stimulated RAB18 GTP-hydrolysis promotes its
retargeting to the Golgi. Without TBC1D20-stimulated RAB18
GTP-hydrolysis at the ER, the fraction of the protein that
is GDP-bound, and therefore the fraction that is subject to
GDI-mediated membrane extraction, is reduced. In turn, a
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Figure 3. RAB18 dynamics at the ER are altered in TBC1D20(p.Gln98*) patient fibroblasts, bs mEFs and TBC1D20-deficient HeLa cells. (a) GFP-RAB18 colocalizes with
staining for GM130 in control but not TBC1D20(p.Gln98*) fibroblasts. (b) GFP-RAB18 dynamics at the ER are altered in TBC1D20(p.Gln98*) fibroblasts when compared
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its targeting to, and association with, the Golgi membrane.
The fluorescence recovery profile of RAB18 was signifi-
cantly different in control and TBC1D20(p.Gln98*) cells
(figure 3b). Fluorescence recovery at the first recorded post-
bleaching timepoint was lower in the TBC1D20(p.Gln98*)
cells, suggesting that in these cells a reduced fraction ofGFP-RAB18 is cytosolic. Further, recovery proceeded at a
slower rate and was less complete than in controls. This
suggests that RAB18 is more stably ER-associated in these
cells, as predicted if TBC1D20 functions as a RAB18GAP.
Because TBC1D20 has previously been characterized as a
GAP for Rab1 isoforms [14,21], we carried out FRAP exper-
iments with GFP-RAB1A to test whether altered dynamics
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fluorescence recovery was very rapid in both control and
TBC1D20(p.Gln98*) fibroblasts and we were therefore unable
to distinguish recovery profiles (electronic supplementary
material, figure S3).
To determine whether the altered localization and
dynamics of RAB18 seen in patient fibroblasts represent a
consistent feature of cells lacking TBC1D20, we examined
RAB18 in the bs mEFs (figure 3c). Interestingly, we found
that the perinuclear enrichment of RAB18 was less pro-
nounced in both bs/þ and bs/bs cells than in the human
fibroblasts. Further, the colocalization between RAB18 and
GM130 was less complete and did not differ between bs/þ
and bs/bs cells. FRAP experiments, however, revealed that
as in the human fibroblasts, RAB18 was less cytosolic and
more stably ER-associated in the TBC1D20-deficient cells
(figure 3d ). Thus, TBC1D20 promotes dissociation of
RAB18 from the ER membrane in both cell types.
It was possible that redistribution of RAB18 was not seen
in the bs/bs mEFs because of some residual activity of the
mutant TBC1D20 protein. To explore this possibility and
also to examine RAB18 dynamics in an otherwise isogenic
background, we used CRISPR technology [22] to target
TBC1D20 in HeLa cells. In order to guard against potential
off-target effects, we used Cas9 nickase to induce paired
single-strand breaks in the gene. Further, we used two pairs
of guide RNAs to produce one cell line in which TBC1D20
was mutated in exon 5, and one cell line in which it was
mutated in exon 7. For both cell lines, cloning of the targeted
exons showed that the gene was mutated and western blot-
ting indicated that TBC1D20 protein was absent (electronic
supplementary material, figure S4). As with the bs/bs
mEFs, we found that loss of TBC1D20 in the HeLa cell lines
did not lead to an appreciable change in RAB18 localization
(figure 3e). Once again, however, RAB18 dynamics were
altered indicating its more stable ER-association in mutant
compared with control cells (figure 3f ). The reproducibility
of the FRAP approach is illustrated by the fact that fluor-
escence recovery profiles from the two CRISPR mutant cell
lines are almost identical (figure 3f ).
2.4. A reduced fraction of cellular RAB18 is cytosolic in
TBC1D20-deficient human fibroblasts, mouse
fibroblasts and HeLa cells
Transient knockdown of TBC1D20 in Cos7 cells has been
shown to cause redistribution of RAB18 within the ER and
an ‘ER sheet spreading’ phenotype [11]. This is a potential
confounding factor in interpretation of our FRAP exper-
iments, because a change in ER structure in the absence of
TBC1D20 might underlie the apparent change in RAB18
dynamics. We view this as unlikely, because similarly altered
ER structure in RAB3GAP1(c.649-2A.G) cells [11] had
no significant effect on RAB18 dynamics (figure 2c).
However, we nevertheless carried out additional experi-
ments to determine more directly whether the loss of
RAB3GAP or TBC1D20 affects the proportion of RAB18
that is cytosolic.
Cells were cotransfected to express GFP-RAB18 and the
cytosolic red fluorescent protein mKATE2. Live cells were then
permeabilized with 10 mM digitonin and the drop in fluor-
escence resulting from diffusion of these proteins out of cellswas recorded.mKATE2 fluorescence diminished rapidly follow-
ing permeabilization and was reduced to a level comparable to
background fluorescence. In contrast, RAB18 fluorescence was
only partially reduced, reflecting the loss of the cytosolic com-
ponent, but the retention of the membrane-associated
component of fluorescence (figure 4).
In the patient fibroblasts, theRAB18 loss followingdigitonin
permeabilization was comparable in control and RAB3GAP1
(c.649-2A.G) cells, whereas that in TBC1D20(p.Gln98*) cells
was significantly less pronounced (figure 4a). RAB18
fluorescence loss was also significantly less pronounced in
TBC1D20-deficient mouse fibroblasts (figure 4b) and HeLa
cells (figure 4c) compared with their respective controls. These
data confirm that RAB18 is less cytosolic in the absence of
TBC1D20, indicating that TBC1D20 promotes dissociation of
RAB18 from the ER membrane and therefore supporting the
suggestion that TBC1D20 functions as a RAB18GAP.
2.5. A model for RAB18 regulation
In this study, we examined the influence of the RAB3GAP
complex and TBC1D20 on RAB18 levels, localization and
dynamics. The data suggest a regulatory cycle whereby
TBC1D20 RAB18GAP activity can act to promote RAB18
membrane extraction from the ER and retargeting to the
cis-Golgi, where RAB3GAP/RAB18GEF can act to recruit
and stabilize it (figure 5). RAB18 has recently been shown
to interact with components of the ‘NRZ complex’, an
ER tethering complex, and so this scheme is consistent
with suggestions that it functions in Golgi-to-ER trafficking
[23]. Interestingly, we also show that RAB18 accumulates
in cells lacking RAB3GAP or TBC1D20, suggesting that
normal RAB18 function, its cycles of GTP-binding and
hydrolysis and/or its effector interactions are coupled to
its degradation.
The clinically indistinguishable effects of loss-of-function
mutations in RAB3GAP1, RAB3GAP2, TBC1D20 or RAB18
imply that correctly regulated GTP-binding and hydrolysis
are equally essential for RAB18 function. In the broader con-
text, this example may serve to distinguish Rab protein
regulation from that of other small GTPases such as Ras.
Mutations in the RasGAP NF1, for example, cause disease as
a result of sustained Ras activation suggesting that Ras GTP-
binding is sufficient for activation of downstream signalling
[24]. In contrast, it appears that the downstream function of
RAB18 is equally dependent on RAB3GAP/RAB18GEF and
TBC1D20/RAB18GAP activity.
Primarily, our data suggest that WarburgMicro syndrome,
whether caused by mutations in RAB3GAP1, RAB3GAP2,
TBC1D20 or RAB18, results from RAB18 dysfunction. It
remains to be determined how RAB18 dysfunction contributes
to disease pathology at a molecular level, but it is hoped that
research in this area will continue.3. Methods
3.1. Antibodies and reagents
Polyclonal rabbit antibodies to RAB3GAP1, used for
western blotting and immunofluorescence, respectively, were
obtained from Bethyl laboratories and Proteintech. A rabbit
polyclonal antibody to TBC1D20 was obtained from Prestige
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Figure 4. The proportion of cytosolic RAB18 in TBC1D20( p.Gln98*) patient fibroblasts, bs mEFs and TBC1D20-deficient HeLa cells is reduced compared to controls.
(a) Loss of cytosolic GFP-RAB18 and mKATE2 fluorescence following permeabilization of human fibroblasts with 10 mM digitonin. Partial loss of GFP-RAB18 flu-
orescence is comparable in control and RAB3GAP1(c.649-2A.G) cells but reduced in TBC1D20( p.Gln98*) cells. mKATE2 fluorescence is reduced close to background
levels in each cell line. (b) Partial loss of GFP-RAB18 fluorescence following digitonin permeabilization is reduced in bs/bs mEFs when compared with bs/þ mEFs (c)
Partial loss of GFP-RAB18 fluorescence following digitonin permeabilization is reduced in TBC1D20-deficient HeLa cells when compared with controls. Data were
combined from at least 10, 22 and 14 cells per condition in (a), (b) and (c), respectively, and are representative of at least three independent experiments. Error bars
represent s.e.m. Scale bars, 10 mm. #p, 0.05 and *p, 0.01, unpaired Student’s t-test.
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RAB18 was generated by Eurogentec to the peptide sequence
N-CESENQNKGVKLSHRE-C. This antibody is specific in
western blotting as it recognizes a protein of the appropriate
size in samples from wild-type and Rab18þ/2 mice, but not
in samples fromRab182/2mice [12]. A rabbit polyclonal anti-
body to RAB1A and a goat polyclonal antibody to b-tubulin
were obtained from Abcam, and monoclonal mouse anti-
GM130 was obtained from BD Biosciences. Plasmids used for
expression of GFP-RAB18 and GFP-RAB1A have been pre-
viously described [11,13]. The plasmid used for expression of
mKATE2 was obtained from Evrogen. Cycloheximide was
obtained from Abcam.3.2. Quantitative PCR
For each qPCR experiment, RNAs were purified from each
cell line using the Qiagen RNAeasy kit according to manufac-
turer’s instructions. cDNAs were then produced immediately
using a first strand cDNA synthesis kit (Roche). qPCR analy-
sis was carried out on a LightCycler 480 instrument (Roche).
PCR amplification was quantified through binding of specific
mono colour hydrolysis probes (Roche) and analysed using
LIGHTCYCLER 480 software v. 1.5.0 (SP4; Roche). Primers
amplifying across exon boundaries were designed using the
coding sequences of RAB3GAP1, TBC1D20, RAB18 and
Rab18 (NCBI reference sequence accessions NM_012233.2,
RAB3GAP
TBC1D20
nucleus
endoplasmic
reticulum
RAB18 GDP
RAB18 GDP GDI
RAB18 GDPRAB18 GTP
RAB18 GTP
cytosol
cis-Golgi
Figure 5. A model for RAB18 regulation. Endoplasmic reticulum (ER)-associated RAB18 hydrolyses bound GTP in a reaction potentiated by TBC1D20 activity. The
resulting GDP-bound RAB18 is susceptible to GDP dissociation inhibitor (GDI)-mediated extraction into the cytosol. Cytosolic RAB18 complexed to GDI can be
targeted to cellular membrane compartments including the ER and the cis-Golgi. GDP-bound RAB18 associated with the cis-Golgi can exchange bound GDP
for GTP in a reaction catalysed by the RAB3GAP complex.
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Universal ProbeLibrary Assay Design Center (Roche). Primers
are listed in the electronic supplementary material, table S1.
3.3. Western blotting
Human fibroblasts, bs mEFs and HeLa cells were seeded on
6-well plates and allowed to grow for 48 h. They were then
trypsinized, washed and lysed on ice in a lysis buffer contain-
ing 0.5% (v/v) Nonidet P-40 in a solution of 150 mM NaCl,
10 mMEDTA and 50 mMTris–HCl (pH ¼ 7.5) towhich a pro-
tease inhibitor cocktail (Roche) was added. Following protein
quantification, samples were combined with a reducing load-
ing buffer and subjected to SDS–PAGE and western blotting
carried out according to standard methods. Each lane on the
blots shown corresponds to an individual lysate sample.
3.4. Cell culture and transfections
Human fibroblasts were cultured in DMEM (Gibco) supple-
mented with 20% fetal calf serum (FCS) and 1% penicillin/streptomycin. bsmEFs and HeLa cells were cultured in a simi-
lar medium containing 10% FCS. Human fibroblasts and bs
mEFs were maintained under hypoxic conditions (3% O2, 5%
CO2) at 378C. HeLa cells were maintained under normoxic
conditions (5% CO2) at 378C.
Transfection of human fibroblasts and HeLa cells was
carried out using Lipofectamine 2000 (Life Technologies)
according to manufacturer’s instructions. Briefly, up to 0.5 mg
plasmid DNA was combined with 1.5 ml Lipofectamine 2000
per transfection and added to cells in a total volume of 500 ml
opti-MEM serum-free media (Gibco) for 4 h. Transfection
mixes were then replaced with full media, and cells were
allowed to recover for 18–24 h prior to fixation or imaging.
Transduction of bs mEFs was carried out using the Neon
system (Life Technologies) according to manufacturer’s
instructions. Briefly, 0.5 mg plasmid DNA was combined
with cells in suspension in a total of 10 ml buffer ‘R’ per electro-
poration and loaded into a 10 ml electroporation tip. Cells were
electroporated with a single pulse at 1350 V with a width of
30 ms and allowed to adhere and recover for 18–24 h in full
media prior to fixation or imaging.
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Cells were seeded on glass coverslips in 24-well plates, at a
density of 1  105 cells per well, then allowed to adhere over-
night and transfected as appropriate. They were then fixed
for 30 min with 4% (w/v) paraformaldehyde in PBS on ice.
Prior to the addition of antibody, coverslips were blocked
in PBS containing 10% (v/v) donkey serum (Sigma-Aldrich)
and 0.1% (v/v) Triton-X-100 (Sigma-Aldrich) for 1 h at
room temperature. Coverslips were probed with primary
antibodies (see above) in blocking buffer, overnight at 48C.
They were then washed with PBS, and probed with Alexa
Fluor 488 or Alexa Fluor 594-conjugated donkey anti-mouse
or anti-rabbit secondary antibody as appropriate (Life Tech-
nologies) for 1 h at room temperature in blocking buffer.
Following an additional round of washing, they were
mounted and stained with DAPI prior to imaging.473.6. Confocal microscopy
Imaging was carried out on a Nikon A1R confocal microscope
equipped with the Nikon Perfect Focus System using a 60 oil
immersion objectivewith a 1.4 numerical aperture. In immuno-
fluorescence experiments, the pinhole was set to airy1. DAPI
was excited using a 403.5 nm laser, and emitted light was col-
lected at 425–475 nm. Alexa Fluor 488 or GFP was excited
using a 488 nm laser, and emitted light was collected at 500–
550 nm. Alexa Fluor 594 was excited using a 561.3 nm laser,
and emitted light was collected at 570–620 nm.
In FRAP and digitonin-permeabilization experiments,
cells were seeded onto glass-bottomed dishes (Mattek) and
imaged 18–24 h post-transfection. Dishes of control and
mutant cells were alternated over the course of imaging. The
pinhole was set to airy2 and digital zoom parameters were
kept constant for each cell type. In bleaching experiments,
cells were maintained in HBSS, and bleaching was carried
out using 90% laser power. In permeabilization experiments,
cells were maintained in a ‘cytosol-like’ buffer containing
20 mM HEPES (pH ¼ 7.05), 140 mM KCl, 10 mM KH2PO4,
5 mM MgCl2, 5.5 mM glucose and 100 mM ATP. Cells were
permeabilized with 10 mM digitonin, and fluorescence lossrecorded from ROIs drawn to exclude nuclei and ‘perinuclear’
GFP-RAB18.
3.7. Generation of cell lines
Primary mouse embryonic fibroblasts from blind-sterile (bs)
mice were generated and maintained as previously described
[6]. bs/þ and bs/bs lines were transfected with the Simian
virus-40 large-T antigen (SV40) vector pBSSVD2005 (Addgene)
using Lipofectamine 3000 (Life Technologies) according to
manufacturer’s instructions. Primers used to determine geno-
type at the bs locus and incorporation of SV40 are listed in
the electronic supplementary material, table S1.
In order to specifically target TBC1D20 in HeLa cells with
Cas9 nickase, pairs of guide RNAs were selected using the
online CRISPR design tool (http://crispr.mit.edu/). Oligonu-
cleotide pairs incorporating these guide RNA sequences (see
the electronic supplementary material, table S1) were then
annealed and ligated into pX461 and pX462 plasmids
(Addgene). Sequences were verified by direct sequencing.
HeLa cells were then cotransfected with the recombinant
plasmids. Each recombinant plasmid drives expression
of Cas9 nickase, one guide RNA, and GFP or a puromycin-
resistance gene, respectively. Twelve hours following
transfection, cells were treated with 1 mg ml21 puromycin
for 24 h and then allowed to recover for a further 12 h.
They were then trypsinized and single, cotransfected, GFP-
expressing cells were sorted into 96-well plates using a FACS-
Aria2 SORP instrument (BD). After sufficient growth, clones
were analysed by PCR and western blotting.
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